Russian Scientists Announce Breakthrough mRNA Cancer Vaccine ‘Enteromix’

Russian scientists have unveiled Enteromix, an mRNA-based cancer vaccine that has shown 100% efficacy in clinical trials. The vaccine demonstrated remarkable outcomes in shrinking tumours and slowing their growth, and was found safe for repeated use.

Personalized Immunotherapy

• Enteromix is a personalized therapy, tailored to each patient’s tumour profile.
• It uses sophisticated mutation-profiling algorithms to design a dose specific to an individual’s tumour genomics, making it a biomarker-driven immunotherapy.
• Initially, it will be deployed against colorectal cancer, one of the most common malignancies.
• Vaccines targeting aggressive skin and brain cancers are currently in the pipeline.

How It Works: The Role of mRNA

• mRNA (messenger RNA) carries genetic instructions from DNA to the cell’s protein-making machinery.
• In vaccines, mRNA trains cells to produce a harmless piece of a virus or cancer antigen.
• This triggers the immune system to recognize and attack tumour cells, strengthening the body’s defense.